In DLNs, as in tumor, CD8+ T cell population and activity increased in the combination therapy group (Figure 4G-H), and the T cell exhaustion markers PD-1 and Tim3 were decreased in the same group (Figure 4I-J). The gene discussed is CD8A; the disease is neoplasm.